Corporate Profile 2020-2021 - Alfresa Group
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Alfresa Group Corporate Profile 2020-2021
Message from the President The Alfresa Group’s Principles
We create and deliver
a fresh life for all The Alfresa Group’s Principles
Our Philosophy
We create and deliver a fresh life for all.
With “Our Philosophy” to create and deliver a fresh life for all,
Our Vision
the Alfresa Group engages in reliable, safe and sincere
We aim to become a Healthcare Consortium that provides
business practices. products and services in every health-related field.
Our Promises
In its super-aged society, Japan’s national healthcare system
is facing a major turning point including the advance of an Reliability Safety Sincerity
integrated community care system that provides integrated
medical care, nursing care, and other services within • We always provide reliable products and services and strive to enhance customer satisfaction.
local communities. • We respect individual characteristics and personalities and strive to maintain and improve a pleasant
working environment.
Under such a situation, the Alfresa Group has implemented our • We raise corporate value as a corporate group operating in the health-related industry.
2019-21 Mid-term Management Plan The Challenge of Further
• We conduct proper trade under fair and free competition.
Growth “Together with Health, Together with Communities.” We are
• We strive to proactively engage with society by providing appropriate information in a timely manner.
bringing together all capabilities of the Group in aiming to
• We contribute to local communities through our business operations.
realize “Healthcare Consortium” that provides products and
services in every health-related field. • We strive to protect the global environment.
Moreover, in 2020, COVID-19 has substantially affected the
health of people around the world and changed people’s mindset
of both medical care and disease prevention. Redefining our Corporate Overview
responsibility for the stable supply of pharmaceuticals as a part As of June 25, 2020
of social infrastructure, the Alfresa Group goes forward with our Corporate Name: Alfresa Holdings Corporation
Address: 1-1-3, Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan
social mission which is the secure distribution of pharmaceuti-
Established: September 29, 2003
cals — what's needed, when needed, and where needed.
Management of subsidiaries that deal with wholesaling, manufacturing, marketing and import/export of pharmaceuticals,
Business:
diagnostic reagents, medical devices/equipment, etc., and operating dispensing pharmacies and conducting related businesses.
Now and in the future, the Alfresa Group keeps challenging to be Paid-in Capital
¥18,454 million
(Consolidated):
a corporate group that is indispensable to society.
Net Sales (Consolidated): ¥2,698,511 million (Fiscal year ended March 31, 2020)
Taizo Kubo Director & Chairman Kenji Kuwayama Audit & Supervisory Board Member
Ryuji Arakawa Representative Director & President (Standing)
Yasuki Izumi Director, Deputy President Masakazu Ozaki Audit & Supervisory Board Member
(Standing)
Seiichi Kishida Director, Senior Vice President
& Executive Officer Seisui Kamigaki Audit & Supervisory Board Member
(Outside)
Directors and Audit & Hisashi Katsuki Director
Supervisory Board Yoshitaka Kato Audit & Supervisory Board Member
Koichi Shimada Director (Outside)
Ryuji Arakawa Members:
Yusuke Fukujin Director Takashi Ito Audit & Supervisory Board Member
Representative Director & President Yoichiro Yatsurugi Director (Outside Director) (Outside)
Alfresa Holdings Corporation Takashi Hara Director (Outside Director)
Manabu Kinoshita Director (Outside Director)
Toshie Takeuchi Director (Outside Director)
Introduction to Our Integrated Report
Please view the Alfresa Group’s Integrated Report for more information about the Group.
www.alfresa.com/eng/ir/library/annual_report/
Alfresa Group Corporate Profile 2020-2021 1
Our Vision Toward the Realization of “Healthcare Consortium”
Under the Alfresa Group’s principles, Our Vision is described as, “We aim to become a Healthcare The Alfresa Group is advancing initiatives in accordance with five group management policies
Consortium that provides products and services in every health-related field.” We are working under the 2019-21 Mid-term Management Plan The Challenge of Future Growth
together to realize this vision while leveraging Group synergies. Going forward, we will expand from “Together with Health, Together with Communities.”
businesses primarily focused on pharmaceuticals into a wide range of health-related domains.
2019-21 Mid-term The Challenge of Further Growth
Management Plan
“Together with Health,
Together with Communities”
The Realization of “Healthcare Consortium”
Group Management Policies
Realization of “Healthcare Consortium” means the establishment of a system 1. Build up a Group 2. Reform Business Models
that can contribute to people’s lives and health by forming alliances not only with
Collaboration Structure The Group will expand fields from a pharmaceuticals-
Group companies but also with other firms in the healthcare business to offer
The Group will strengthen collaboration among its various based business to wide-ranging businesses in the health
comprehensive medical care and healthcare information, products and services. business segments to further exert its comprehensive field. The Group will reform the business model through
strengths. The Group will also actively promote collabora- active investment in growth fields, and aim at construct-
tion with companies in other industries in the growth fields. ing solid business foundations toward further growth.
3. Contribute to the Health of Community Members
Manufacture
Medical Diagnostic
Self-Medication Pharmaceuticals The Group will construct an “Local community health and medical care platform” in collaboration with wide-ranging service providers
Devices Reagents
Products Manufacture Manufacture open platform that links
Manufacture Manufacture Future Model
Travel agencies Credit
various stakeholders (travel by type of companies
involved with integrated disease) (credit settlement)
community care system. Insurance companies
Integrated Community Care System
Housing manufacturers
(insurance coverage by type Linking medical care, nursing care, (housing by type of disease)
The Group will evolve into of disease) home care, municipalities, etc
the role of comprehensively
supporting community Data health service Health management
Medical Diagnostic providers companies
medicine, and aim to build Medical device Dispensing Municipalities, Medical Nursing care Transportation
Wholesale
Self-Medication Ethical Pharmaceuticals (data analysis manufacturers pharmacies Government institutions facilities service (home care by type of disease)
SPD Devices Reagents a“local community health by type of disease) companies
Products Wholesale Wholesale
Wholesale Wholesale and medical care
Manufacturers
platform”collaborating with (foods)
Nutritional guidance Housing manufacturers
wide-ranging service service providers (housing fit for cognitive
disease patients)
providers in the future.
4. Further Improve 5. Develop Talent
Dispensing Pharmacies / Productivity The Group will execute talent develop- Alfresa Group’s
Retail
Medical-Related Services
While continuing present initiatives to ment strategies, focusing on “Willingness Four Requirements for
boost efficiency, the Group will to venture into uncharted areas” and Our Valuable People
increase efficiency of existing opera- “Ability to adapt to changing environ-
tions utilizing new technologies in ments” among the Alfresa Group’s four
Willingness to Strong sense
Prevention Cure / Diagnosis / Treatment order to reallocate management requirements for our valuable people. venture into of mission
uncharted areas for work that
(OTC drugs, health foods, vaccines, etc.) (ethical pharmaceuticals, diagnostic reagents, medical devices, medical materials, etc.) resources to new operations and supports life
Talent development strategies
further improve productivity.
1. Reinforce OJT
2. Realize career plans which expand growth
opportunities Ability to adapt High ethical
to changing standards
3. Secure diverse personnel and have them environments that earn trust
play active roles
4. Reform training programs
2 Alfresa Group Corporate Profile 2020-2021 Alfresa Group Corporate Profile 2020-2021 3
Our Business
The Alfresa Group’s main businesses are the Ethical Pharmaceuticals Wholesaling Business, through the development of various businesses relating to health and medical care to
the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the contribute to people’s health.
Medical-Related Business. We are striving for the realization of “Healthcare Consortium”
Ethical Pharmaceuticals Wholesaling Business Manufacturing Business
Focusing on ethical pharmaceuticals, we deliver a wide range of products, including diagnostic reagents, medical From a comprehensive perspective encompassing prevention, diagnosis, and treatment, we manufacture and
devices/materials and nutritional foods, from our high-capacity distribution centers nationwide to hospitals, clinics, market high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices
and dispensing pharmacies. In addition, our sales force with extensive knowledge provides support to our that meet GMP* and QMS* requirements. We research, develop, manufacture and market unique and distinctive
customers. We are contributing to the health of community members by meeting their various healthcare needs.
products, and undertake contract manufacturing of pharmaceuticals.
*GMP: Good Manufacturing Practice, standards for manufacturing control and quality control of pharmaceuticals and quasi-drugs
*QMS: Quality Management System, standards for manufacturing control and quality control of medical devices and external diagnostic reagents
Distribution center Product delivery Marketing activities by MS* Research & development Pharmaceuticals for central nervous system Marketing activities by MR*
*Marketing Specialist of pharmaceuticals wholesaling *Medical Representative of pharmaceuticals information
Collaboration across business segments Delivering the Group synergies
Self-Medication Products Wholesaling Business Medical-Related Business
Focusing on over-the-counter drugs, we deliver health foods, supplements and other products to drugstores and The Alfresa Group is actively expanding its business areas toward the realization of “Healthcare Consortium.” We are
pharmacies, meeting customer needs with a full product lineup, reliable product supply system, and high-value- meeting a variety of medical needs through our dispensing pharmacy business and other medical-related businesses.
added marketing activities such as how to create optimal storefronts. In our dispensing pharmacy business, we pursue further added value as a community-based pharmacy.
A part of product lineup Shelving allocation proposal Solution-proposal business conference Dispensing pharmacy Consultation with patients Community event “Children’s pharmacy”
Overseas Business Development
We are expanding our business mainly in Asia through our own initiatives as
well as partnerships with overseas companies.
Signing ceremony with China Resources Pharmaceutical Commercial Group Co., Ltd.
4 Alfresa Group Corporate Profile 2020-2021 Alfresa Group Corporate Profile 2020-2021 5
Alfresa Group’s Features Talents with a sense of mission
Number of Group employees 14,562* 1
The Alfresa Group is engaged in a range of businesses, from the manufacture of active pharma- MS SA*2 Medical Management Pharmacists
(sales workers) (delivery workers) Specialists*3
ceutical ingredients (API), to the manufacture and wholesale of pharmaceuticals and other
products, to the operation of dispensing pharmacies. Through the unified development of these
businesses, the Group strives to meet the full range of medical needs.
3,423 2,240 1,873 1,241
Over 14,000 of our people*4 are working as one, with a strong sense of mission, to promote their business as one of social
infrastructure which must not be interrupted at any time.
*1 The number includes 2,488 part-time and temporary employees.
*2 Sales Assistant
*3 It is a qualification recognized by the Japan Medical Management Practice Association.
*4 The Alfresa Group refers to its employees as “our people.”
Ethical Pharmaceuticals Wholesaling Business
Manufacturing Business Medical-Related Business
Self-Medication Products Wholesaling Business
Pharmaceuticals
Wholesalers
Medical Patients
Ethical pharmaceuticals
Institutions
wholesaling
5 production bases Pharmaceuticals Hospitals, Clinics,
550 Manufacturers We are establishing a distribution system to No.1 sales*
Nursing care facilities, We operate 169 dispensing pharmacies, mainly in
etc. the Kanto and Tohoku regions, stretching from
Handling approx. meet needs of our customers including medical Hokkaido to the Kansai region. At the stores, we
kinds of items institutions, dispensing pharmacies, and * Fiscal year ended March 31, 2020
actively communicate with local communities by
Retailers
Source: “ 2020 All Data & Ranking” published by
drugstores by effectively allocating high-capacity Drug Magazine (Drugmagazine Co., Ltd.) providing events such as healthcare consultation
distribution centers and “closer to customers” meetings and work experience programs for
warehouses through a network of branches and Dispensing pharmacies, children at pharmacies. Furthermore, around 800
offices nationwide. We deliver products, services Drugstores “dementia supporters” always take care to
and information with around 7,000 vehicles. provide appropriate help in a timely manner.
We have four domestic plants in Akita, Gunma,
We hold the position of Japan’s top wholesaler of
Chiba, and Okayama, as well as one overseas
plant in Qingdao, China. We have a lineup of
ethical pharmaceuticals, which is driven by broad Dispensing
approximately 550 items including pharmaceuti-
transactions with pharmaceuticals manufacturers,
pharmacies
169
a robust distribution platform, and strong relation-
cals, diagnostic reagents, medical devices, and
ships of mutual trust with customers. Moreover,
active pharmaceutical ingredients (API).
Our primary areas of expertise are to develop
Nationwide leveraging the advantages and assets that come stores
pharmaceuticals with this top position, we are aiming to create new
Suppliers
and manufacture pharmaceutical products for
central nervous system diseases such as sleep
distribution network
value by playing the role of connecting medical care, Dementia supporters*
800
nursing care, municipalities, and other entities.
disorders and epilepsy, medical equipment
246
systems for colorectal cancer screening, various
approx.
point-of-care testing (POCT) reagents for infec-
distribution bases
tious diseases, and medical equipment such as * Those who have an accurate knowledge
and understanding of dementia and can
surgical sutures. support dementia patients and their
families in the community.
Procurement Production Distribution Sales
Integrated supply chain for medical and pharmaceutical products * The figures shown above are
as of March 31, 2020.
6 Alfresa Group Corporate Profile 2020-2021 Alfresa Group Corporate Profile 2020-2021 7
Alfresa Group Companies and Ethical Pharmaceuticals
Distribution Network As of June 25, 2020
Building an optimal distribution network with a view
Ethical Pharmaceuticals Wholesaling Business
to nationwide distribution to realize a stable supply
1 Alfresa Corporation 2 Shikoku Alfresa Corporation
Representative: Yusuke Fukujin, President Representative: Masahiko Ogura, President
of pharmaceuticals
Head office: 7, Kanda-Mitoshirocho, Chiyoda-ku, Tokyo Head office: 1255-10, Fuke Kou, Kokubunjicho, Takamatsu, Kagawa Prefecture
Business domain: Ethical pharmaceuticals wholesaling business Business domain: Ethical pharmaceuticals wholesaling business
Distribution bases of Ethical Pharmaceuticals
3 TS Alfresa Corporation 4 Meisho Co., Ltd.
Wholesaling Business
Representative: Yuji Tsukimori, President Representative: Kenji Orimoto, President
Head office: 1-2-19, Shoko Center, Nishi-ku, Hiroshima, Hiroshima Prefecture Head office: Ha 1, Muryojimachi, Kanazawa, Ishikawa Prefecture Distribution Center
Business domain: Ethical pharmaceuticals wholesaling business Business domain: Ethical pharmaceuticals wholesaling business Pharmaceuticals Center
13
5 RYUYAKU CO., LTD. 6 Tohoku Alfresa Corporation Circled numbers indicate head offices of Alfresa Group companies.
Representative: Tadashi Inamine, President Representative: Keiji Kawashima, President
Head office: 5-6-5, Makiminato, Urasoe, Okinawa Prefecture Head office: 1-46-1, Kikutamachi Oroshi, Koriyama, Fukushima Prefecture
Business domain: Ethical pharmaceuticals wholesaling business Business domain: Ethical pharmaceuticals wholesaling business
Meisho Co., Ltd. Head Office Distribution Center Hanamaki Distribution Center
6 Tohoku Alfresa
7 Alfresa Medical Service Corporation 8 Alfresa Shinohara Chemicals Corporation Koriyama Distribution Center Corporation
Representative: Seiji Nakamura, President Representative: Yuichi Shinohara, President
Aichi Distribution Center
Head office: 1-12-1, Uchikanda, Chiyoda-ku, Tokyo Head office: 9-41, Minamigoza, Kochi, Kochi Prefecture 4
Business domain: SPD business (contract distribution service in hospitals) Business domain: Wholesaling business of diagnostic reagents, research 12 Osaka Distribution Center
and wholesaling of medical materials reagents, nursing care equipment, and analytical equipment
Hyogo Distribution Center
for laboratories, etc. Alfresa
Corporation
11
3 Shizuoka Pharmaceuticals Center
Self-Medication Products Wholesaling Business Fukuoka Distribution
2
Kyoto Pharmaceuticals Center
Alfresa Corporation
Center
8
Shikoku Distribution Center
Shikoku Alfresa
9 Alfresa Healthcare Corporation
10 Mogi Pharmaceutical Co., Ltd. Corporation
Representative: Hisashi Katsuki, President
Head office: 3-11-5, Nihonbashi-Honcho, Chuo-ku, Tokyo Representative: Yusuke Mogi, President
Onomichi Distribution Center TS Alfresa
Business domain: Self-medication products wholesaling business Head office: 3-9-7, Nihonbashi-Honcho, Chuo-ku, Tokyo
Business domain: Self-medication products wholesaling business Ube Distribution Center Corporation
RYUYAKU CO., LTD. Head Office
Distribution Center
Manufacturing Business
5
11 Alfresa Pharma Corporation 12 QINGDAO NESCO MEDICAL CO., LTD.
Representative: Koichi Shimada, President and CEO Representative: Keiji Ito, Chairman
Head office: 2-2-9, Kokumachi, Chuo-ku, Osaka, Osaka Prefecture Head office: No.11 Xinghai Rd., Chengyang, Qingdao, Shandong, China
Business domain: Manufacturing, import/export and marketing of Business domain: Manufacturing, export and sale of surgical sutures
pharmaceuticals, diagnostic reagents, medical devices,
and materials for pharmaceuticals, etc. 14 Sannova Co., Ltd.
Representative: Toru Takekawa, President Enlargement of the Tokyo Metropolitan Area
13 Alfresa Fine Chemical Corporation Head office: 3038-2, Seradacho, Ota, Gunma Prefecture
Representative: Yoshinobu Oshima, President and CEO Business domain: Research, development, manufacturing and sales of
14
Head office: 1-10-1, Mukaihama, Akita, Akita Prefecture pharmaceuticals and quasi-drugs, etc.
Business domain: Manufacturing of active pharmaceutical ingredients
Gunma Distribution Center
Saitama Distribution Center
Medical-Related Business
16
15 Apollo Medical Holdings Inc.
16 Nihon Apoch Co., Ltd.
Representative: Tomohide Tsuzuku, President 1 7 15
Head office: 2-45-8-8F, Minamiotsuka, Toshima-ku, Tokyo Representative: Shizuhisa Kanemoto, President 9 10 17
Business domain: Dispensing pharmacy business Head office: 6-20, Wakitahoncho, Kawagoe, Saitama Prefecture
Edogawa Pharmaceuticals Center
Business domain: Dispensing pharmacy business
Bunkyo Pharmaceuticals Center Alfresa Corporation
Meguro Pharmaceuticals Center
Information System Business for the Alfresa Group
17 Alfresa System Corporation Business domain: Operation, maintenance and development of information system
for the Alfresa Group
Representative: Naruhiko Sano, President
Head office: 1-1, Kandanishikicho, Chiyoda-ku, Tokyo
Chiba Distribution Center
Kanagawa Distribution Center
8 Alfresa Group Corporate Profile 2020-2021 Alfresa Group Corporate Profile 2020-2021 9
The name “Alfresa” combines
the English word “all” with
an Esperanto word “fresa” which means “fresh.”
The corporate name symbolizes our wish to be a corporation that “contributes to the happiness of
all people by meeting their healthcare needs and creating an active lifestyle for the coming era.”
This product is made of material from well-managed, FSC®-certified forests and other controlled sources. Printed in Japan
You can also read
